Kristofer Svensson
Director of Finance/CFO bei GABATHER AB
Profil
Kristofer Svensson currently works at Gabather AB, as Chief Financial Officer, Bioextrax AB, as Chief Financial Officer from 2023, Sinfonia Biotherapeutics AB, as Chief Financial Officer from 2022, Ectin Research AB, as Chief Financial Officer, and Melius Pharma AB, as Chief Financial Officer from 2022.
Mr. Svensson also formerly worked at Sensidose AB, as Chief Financial Officer from 2017 to 2022.
Mr. Svensson received his graduate degree from the University of Stockholm.
Aktive Positionen von Kristofer Svensson
| Unternehmen | Position | Beginn |
|---|---|---|
| GABATHER AB | Director of Finance/CFO | - |
| BIOEXTRAX AB | Director of Finance/CFO | 01.01.2023 |
| ECTIN RESEARCH AB | Director of Finance/CFO | - |
Melius Pharma AB
 Melius Pharma AB Pharmaceuticals: MajorHealth Technology Melius Pharma AB is a Swedish clinical stage pharmaceutical company that develops new treatments for chronic cough in idiopathic pulmonary fibrosis (IPF) patients. The company is based in Lund, Sweden and is privately owned, benefiting from the support of two of Sweden's most prominent professional life science investors who bring expertise to develop the company. IPF is a chronic, progressive lung inflammation characterized by fibrosis and disruption of normal lung architecture. Melius Pharma has developed ME-015, which stabilizes ion channels in the neuronal endings in the lungs that mediate cough. ME-015 is presumed to have an acute effect and is a solution for chronic cough, which is one of the major symptoms experienced by 80%% of IPF patients. | Director of Finance/CFO | 01.05.2022 |
Sinfonia Biotherapeutics AB
 Sinfonia Biotherapeutics AB BiotechnologyHealth Technology Sinfonia Biotherapeutics AB is a Swedish clinical stage company that develops biologics for neuropathic pain. The private company is based in Huddinge, Sweden. | Director of Finance/CFO | 01.01.2022 |
Ehemalige bekannte Positionen von Kristofer Svensson
| Unternehmen | Position | Ende |
|---|---|---|
| SENSIDOSE AB | Director of Finance/CFO | 01.10.2022 |
Ausbildung von Kristofer Svensson
| University of Stockholm | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| GABATHER AB | Health Technology |
| ECTIN RESEARCH AB | Health Technology |
| SENSIDOSE AB | Electronic Technology |
| BIOEXTRAX AB | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Sinfonia Biotherapeutics AB
Sinfonia Biotherapeutics AB BiotechnologyHealth Technology Sinfonia Biotherapeutics AB is a Swedish clinical stage company that develops biologics for neuropathic pain. The private company is based in Huddinge, Sweden. | Health Technology |
Melius Pharma AB
Melius Pharma AB Pharmaceuticals: MajorHealth Technology Melius Pharma AB is a Swedish clinical stage pharmaceutical company that develops new treatments for chronic cough in idiopathic pulmonary fibrosis (IPF) patients. The company is based in Lund, Sweden and is privately owned, benefiting from the support of two of Sweden's most prominent professional life science investors who bring expertise to develop the company. IPF is a chronic, progressive lung inflammation characterized by fibrosis and disruption of normal lung architecture. Melius Pharma has developed ME-015, which stabilizes ion channels in the neuronal endings in the lungs that mediate cough. ME-015 is presumed to have an acute effect and is a solution for chronic cough, which is one of the major symptoms experienced by 80%% of IPF patients. | Health Technology |
